Preoperative Botulinum Toxin Type A Use in Giant Inguinal Hernia Repair: A Scoping Review
Open Access
- 13 March 2026
- journal article
- review article
- Published by MDPI AG in Medical Sciences
- Vol. 14 (1) , 135
Abstract
Purpose: Giant inguinal hernias (GIHs) are rare and technically demanding conditions, associated with loss of domain and abdominal wall compliance. Preoperative botulinum toxin type A (BtxA) has been increasingly used in complex ventral hernia repair to facilitate abdominal wall relaxation; however, its role in GIHs surgery remains poorly defined. This scoping review aimed to map the literature on preoperative BtxA use in GIHs repair, focusing on technical protocols, patient selection, and areas of variability. Methods: A scoping review was conducted in accordance with PRISMA-ScR guidelines. MEDLINE, Embase, Web of Science, and Scopus were searched from inception to 10 October 2025. Studies reporting preoperative BtxA administration in adult patients undergoing GIHs repair were included. Data were extracted descriptively and synthesized narratively. Results: Seven observational and non-comparative studies published between 2019–2025 were included, comprising a total of 16 patients. Substantial heterogeneity was observed in BtxA protocols, with total doses ranging from 100 to 450 units, injection timing between 2 and 8 weeks preoperatively, and injection sites varying from 6 to 18. In several reports, BtxA was used as part of a multimodal preoperative strategy including progressive pneumoperitoneum. All studies targeted the lateral abdominal wall musculature, employed imaging guidance, and performed bilateral injections. Patient selection criteria and outcome reporting were inconsistent. Conclusions: Preoperative BtxA use in GIHs repair is limited and heterogeneous. No standardized protocol can be identified. Further anatomically focused and systematically designed studies are required to clarify the role of BtxA and to establish standardized preoperative protocols for this challenging surgical condition.Keywords
This publication has 33 references indexed in Scilit:
- Effect of preoperative botulinum toxin injection in the treatment of giant incisional hernias: a systematic review and meta-analysisHernia, 2025
- Management of giant inguinal hernia; report of four cases and review of literatureHernia, 2025
- Preoperative botulinum toxin for complex abdominal wall reconstruction: a meta-analysis of propensity-score matched studies with trial sequential analysisHernia, 2025
- Management strategy of giant inguinoscrotal hernia—a case series of 24 consecutive patients surgically treated over 17 years periodHernia, 2024
- The effect of preoperative botulinum toxin a injection on traction force during hernia repair: a prospective, single-blind study, intra-patient comparison using contralateral side as a controlHernia, 2024
- Achieving fascial closure with preoperative botulinum toxin injections in abdominal wall reconstruction: outcomes from a high-volume centerUpdates in Surgery, 2024
- Botulinum toxin A in complex incisional hernia repair: a systematic reviewHernia, 2023
- A systematic review and meta-analysis of technical aspects and clinical outcomes of botulinum toxin prior to abdominal wall reconstructionHernia, 2021
- Long-term results of botulinum toxin type A in complex abdominal wall repair and review of the literatureUpdates in Surgery, 2020
- Laparoscopic repair of complex ventral hernia facilitated by pre-operative chemical component relaxation using Botulinum Toxin AHernia, 2016